Grant: Collaborative Research and Development Grants
University of Victoria
$12,600.00
Measurement of the mechanical properties of 3D printed scaffolds using ElastoSens Bio
EF 2018-19
Résumé
Rheolution is a private company that provides innovative solutions to current industrial challenges in materials development and characterization. Rheolution offers to customers around the world cost-effective and high added-value testing instruments for industrial quality and process control as well as research & development. The company has been actively involved in cheese, food and biomaterials industries since their incorporation in 2009. In particular, Rheolution has recently entered the field of tissue engineering and regenerative medicine in which bioengineered tissue-like scaffolds are made from scaffolds and cells for drug screening and organ transplantation. Recently, three-dimensional (3D) printing has emerged as a promising method for precisely depositing biomaterials, cells, and biological factors with exquisite control on their spatiotemporal distribution. However, optimizing the mechanical properties of 3D-printed scaffolds has remained a significant challenge as conventional methods including the use of tensile machines are destructive and cannot provide the full picture of the variations in the mechanical properties of scaffolds over time. As such, the overarching goal of this collaborative research and development proposal is to use the state-of-the-art non-destructive mechanical tester developed by Rheolution (ElastoBio Sens) to measure the mechanical properties of 3D-printed cell-laden scaffolds. We will use a multifaceted approach that combines bioprinting, material sciences, and cell biology to develop protocols for measurement of mechanical properties of cell-laden scaffolds made from an array of bioinks and cells. This technology will allow Rheolution to compete in the ever-increasing market of tissue engineering for drug discovery and organ transplantation. The proposed research is anticipated to result in significant economic gains for BC, QC, and Canada since the targeted technology applies to an emerging and strategic market. Innovations in this area can help reduce the costs associated with current drug development processes and cell-based therapies and transform the health and life sciences sectors.*
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
522685-2017
Name nom
Akbari, Mohsen
Department département
Mechanical Engineering
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2017
Award amount
12600
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1208
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Materials sciences
Area of application fr
Sciences des matériaux
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
1
Application title
Measurement of the mechanical properties of 3D printed scaffolds using ElastoSens Bio
Keyword
NSERC
Application summary
Rheolution is a private company that provides innovative solutions to current industrial challenges in materials development and characterization. Rheolution offers to customers around the world cost-effective and high added-value testing instruments for industrial quality and process control as well as research & development. The company has been actively involved in cheese, food and biomaterials industries since their incorporation in 2009. In particular, Rheolution has recently entered the field of tissue engineering and regenerative medicine in which bioengineered tissue-like scaffolds are made from scaffolds and cells for drug screening and organ transplantation. Recently, three-dimensional (3D) printing has emerged as a promising method for precisely depositing biomaterials, cells, and biological factors with exquisite control on their spatiotemporal distribution. However, optimizing the mechanical properties of 3D-printed scaffolds has remained a significant challenge as conventional methods including the use of tensile machines are destructive and cannot provide the full picture of the variations in the mechanical properties of scaffolds over time. As such, the overarching goal of this collaborative research and development proposal is to use the state-of-the-art non-destructive mechanical tester developed by Rheolution (ElastoBio Sens) to measure the mechanical properties of 3D-printed cell-laden scaffolds. We will use a multifaceted approach that combines bioprinting, material sciences, and cell biology to develop protocols for measurement of mechanical properties of cell-laden scaffolds made from an array of bioinks and cells. This technology will allow Rheolution to compete in the ever-increasing market of tissue engineering for drug discovery and organ transplantation. The proposed research is anticipated to result in significant economic gains for BC, QC, and Canada since the targeted technology applies to an emerging and strategic market. Innovations in this area can help reduce the costs associated with current drug development processes and cell-based therapies and transform the health and life sciences sectors.*